Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial.
about
Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progression-free survival in patients with advanced and/or metastatic colorectal cancerIrinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for advanced and/or metastatic colorectal cancerSequential versus combination chemotherapy for advanced colorectal cancerIrinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for advanced and/or metastatic colorectal cancerProtocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) ..Sequence of treatment in locally advanced and metastatic renal cell carcinomaHow to select the optimal treatment for first line metastatic colorectal cancerCan we predict toxicity and efficacy in older patients with cancer? Older patients with colorectal cancer as an exampleEpidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancerSecond-line systemic therapy for metastatic colorectal cancer.Oral drugs in the treatment of metastatic colorectal cancer.Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancerStrategies of sequential therapies in unresectable metastatic colorectal cancer: a meta-analysis.Reporting of adverse events in randomized controlled trials of highly active antiretroviral therapy: systematic review.A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial.Colorectal carcinoma: the management of polyps, (neo)adjuvant therapy, and the treatment of metastases.C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer.Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancerChemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial.Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: the AIO KRK 0110 trial/ML22011 trial.Understanding chemotherapy treatment pathways of advanced colorectal cancer patients to inform an economic evaluation in the United Kingdom.Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases.Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.Treatment with capecitabine + bevacizumab following induction treatment with FOLFIRI + bevacizumab in metastatic colorectal carcinoma.Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555).Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies.Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841.Colorectal hepatic metastasis: Evolving therapies.Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort.Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Personalized colon cancer care in 2010.Chemotherapy plus percutaneous radiofrequency ablation in patients with inoperable colorectal liver metastasesRelationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis.Developments in treating metastatic colorectal cancer: Recent international reports from ASCO 2007 and 2008.Medical treatment of advanced colorectal cancer in 2009.Is resection of colorectal liver metastases after a second-line chemotherapy regimen justified?
P2860
Q24186145-C0F96CBE-59A2-446B-887D-B96E17D72AB8Q24200737-22F7F338-06B7-4C96-9813-BF3798D07ED6Q24234461-E70C1E9D-BC9F-4980-BE72-5C74628E3244Q24234555-3C57546D-A998-44B7-8D8D-C7FD8C7040A3Q24658529-BDF84ADA-530E-4B42-9686-4CDDEFFAE74CQ26773653-8C246155-05A6-4E4E-966B-3BEB826F0540Q27026516-B7F7DA6A-D809-49A8-B487-B43964179E65Q28069620-DA9DE32F-25E4-4E3C-9C18-26149DEC3321Q28084216-5B9185D1-77DA-4DFD-B587-BE21150882A9Q30238760-A5CF37F6-6837-4059-9C80-25444FBD795AQ30251387-5BE37973-D31C-4C8E-9978-6AC338664679Q33414068-2523C14B-0CC4-4EC6-83CA-23EBB5405B21Q33419230-E70D64B3-8B5C-47E6-BD0E-7B0A2DFE42BDQ33455278-6B4C4259-8308-4F32-BAF5-AD89164CEA40Q33555283-71F2716D-E6E9-4FDE-8F68-C9D045BB83F1Q33576199-6E0E8462-C699-46CE-A4C9-7EF1B2072E90Q33579145-3F3B9C7C-2D3C-4933-804E-CE12B0219689Q33688535-85AF4E09-FCB0-437E-83C4-AE012FEAC30AQ33751177-1169FD80-DEAF-4266-ABD8-9023EEF8394FQ33847848-D360B0D6-B83D-4429-883D-834310081706Q33899433-337C0F39-806B-4C37-BC9B-5EF4442A062EQ33922997-80C7DF36-C0E4-4154-8089-E809A956B3FFQ34001177-651304F2-6F15-4630-9DF6-3BEF7E43B7F7Q34059702-29A69664-8983-46C4-A997-E8C626603C66Q34059726-0CD92441-9006-4F9C-9FEE-86C39592852CQ34148380-B031CA61-1535-4F11-9694-0DF801CB57AFQ34167172-082D6BAC-7D14-49EE-8888-9C3C6C4D1D92Q34222890-4FBFD32F-E47A-4AC1-AE0E-52DF7E1AA011Q34362289-2A4B4CBA-2594-46FB-811B-0E3D4B57C237Q34408875-5E6B5A77-A3AE-4429-B491-3C6852811816Q34606724-B9C27DBE-233C-4EB5-BB17-9FB2989115D5Q34663557-E29BA8D4-CFAA-4E38-B319-41C087D597B4Q34663849-2FFE4B93-9216-4924-A2E9-91239736F152Q34664272-5CF267B8-3CA3-48FE-9666-A63CC302FB23Q34731381-FC83FEEE-8434-4E19-BB8A-2343631406B1Q34873168-24976F14-C0B2-4A56-BA28-681C8F5BCA63Q34996408-EE1CDC09-7F87-480A-A88D-C298F441F092Q35026282-6002AC35-E5C5-4394-AD63-52ABDFC182FEQ35076194-FA8E762D-B3B5-4ED6-9F60-B1DDA57DE7C2Q35082383-023BA4FB-7A4B-40E1-A581-8C6EEE21455A
P2860
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Different strategies of sequen ...... a randomised controlled trial.
@en
Different strategies of sequen ...... sis advanced colorectal cancer
@nl
type
label
Different strategies of sequen ...... a randomised controlled trial.
@en
Different strategies of sequen ...... sis advanced colorectal cancer
@nl
prefLabel
Different strategies of sequen ...... a randomised controlled trial.
@en
Different strategies of sequen ...... sis advanced colorectal cancer
@nl
P2093
P921
P1433
P1476
Different strategies of sequen ...... a randomised controlled trial.
@en
P2093
Angela M Meade
Anthony Maraveyas
Clare Topham
David B Smith
David R Ferry
FOCUS Trial Investigators
Gareth O Griffiths
Jonathan A Ledermann
Lindsay Thompson
Mahesh K B Parmar
P304
P356
10.1016/S0140-6736(07)61087-3
P407
P577
2007-07-01T00:00:00Z